Stay updated on APL-2 in Neovascular AMD Clinical Trial
Sign up to get notified when there's something new on the APL-2 in Neovascular AMD Clinical Trial page.

Latest updates to the APL-2 in Neovascular AMD Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedLocations section reorganized to consolidate site listings under a single Locations heading, now including CA, MD, OH, and TX entries, with the revision updated to v3.3.3.SummaryDifference0.6%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedThe page now lists revision: v3.3.2 in the study documents area, replacing v3.2.0.SummaryDifference0.1%

- Check55 days agoChange DetectedRemoved the government funding/operating status notice from the page; the record now presents only the study details and related information.SummaryDifference0.4%

- Check69 days agoChange DetectedNo additions or deletions were detected; the page content remains the same with only cosmetic layout updates.SummaryDifference0.4%

- Check98 days agoChange Detected- Added a prominent operating-status notice and a link to cc.nih.gov/opm.gov for updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference4%

- Check105 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%

Stay in the know with updates to APL-2 in Neovascular AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-2 in Neovascular AMD Clinical Trial page.